Shares of IAC Inc. (NASDAQ:IAC – Get Free Report) have received an average recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $60.31.
IAC has been the topic of several analyst reports. Benchmark reduced their price objective on IAC from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Citigroup reduced their price target on IAC from $47.55 to $45.00 and set a “buy” rating on the stock in a research report on Friday, April 25th. Oppenheimer lowered their price objective on IAC from $72.00 to $70.00 and set an “outperform” rating for the company in a research report on Thursday, February 13th. Truist Financial reduced their target price on shares of IAC from $80.00 to $76.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Finally, JPMorgan Chase & Co. lowered their price target on shares of IAC from $60.00 to $45.00 and set an “overweight” rating for the company in a report on Tuesday, April 22nd.
Check Out Our Latest Stock Analysis on IAC
IAC Stock Performance
IAC (NASDAQ:IAC – Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported ($2.80) earnings per share for the quarter, beating analysts’ consensus estimates of ($3.94) by $1.14. The business had revenue of $570.49 million during the quarter, compared to analysts’ expectations of $809.18 million. IAC had a negative net margin of 14.18% and a negative return on equity of 7.98%. The business’s revenue for the quarter was down 8.6% on a year-over-year basis. During the same period last year, the business earned $0.51 earnings per share. On average, analysts expect that IAC will post 0.43 EPS for the current year.
Institutional Trading of IAC
Institutional investors and hedge funds have recently made changes to their positions in the company. Aster Capital Management DIFC Ltd lifted its stake in IAC by 287.4% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 616 shares of the company’s stock valued at $27,000 after buying an additional 457 shares during the last quarter. TD Private Client Wealth LLC increased its holdings in shares of IAC by 282.2% in the 1st quarter. TD Private Client Wealth LLC now owns 581 shares of the company’s stock valued at $27,000 after acquiring an additional 429 shares during the period. Parallel Advisors LLC raised its position in IAC by 1,422.0% in the 1st quarter. Parallel Advisors LLC now owns 624 shares of the company’s stock valued at $29,000 after purchasing an additional 583 shares during the last quarter. Fifth Third Bancorp boosted its stake in IAC by 426.1% during the 1st quarter. Fifth Third Bancorp now owns 626 shares of the company’s stock worth $29,000 after purchasing an additional 507 shares during the period. Finally, Versant Capital Management Inc grew its position in IAC by 118.6% during the 1st quarter. Versant Capital Management Inc now owns 680 shares of the company’s stock worth $31,000 after purchasing an additional 369 shares during the last quarter. 88.90% of the stock is owned by hedge funds and other institutional investors.
IAC Company Profile
IAC Inc, together with its subsidiaries, operates as a media and internet company worldwide. The company publishes original and engaging digital content in the form of articles, illustrations, and videos and images across entertainment, food, home, beauty, travel, health, family, luxury, and fashion areas; and magazines related to women and lifestyle.
See Also
- Five stocks we like better than IAC
- Compound Interest and Why It Matters When Investing
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Russell 2000 Index, How Investors Use it For Profitable Trading
- The Top-Ranked Insider Buys From April by Market Cap
- How to trade using analyst ratings
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for IAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IAC and related companies with MarketBeat.com's FREE daily email newsletter.